There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were ...

Patients with diabetic macular edema treated with intravitreal aflibercept have a significantly higher risk of adverse renal events compared with those treated with ranibizumab.

The following is a summary of “Impact of aminoglycosides on survival rate and renal outcomes in patients with urosepsis: a ...

BY SYLVESTER OJENAGBON Chronic kidney disease is a significant public health concern in Nigeria. Studies show its ...

Proenkephalin A 119-159 (penKid) has been successfully integrated into daily practice in intensive care unit (ICU), ...

The global continuous renal replacement therapy market revenue was around US$ 1.5 billion in 2021 and is estimated to reach US$ 2.8 billion by 2031, growing at a compound annual growth rate (CAGR) of ...

Clinical trials suggesting that hemodiafiltration offers a survival benefit over hemodialysis have largely been conducted among the prevalent dialysis population, so investigators examined an incident ...